Real-world data show DoxyPEP implementation among PrEP users significantly reduces the incidence of chlamydia and syphilis.

Patients with GCA or AAV were associated with an increased risk for hospitalization due to pneumonia compared with members of the general population.

The FDA issued a second Complete Response Letter for tabelecleucel, citing concerns over trial design and data interpretability in EBV+ PTLD.

Federal regulators escalated a nationwide cheese recall to their most serious warning level after lab tests confirmed presence of Listeria.

A new review suggests that the FDA usually followed the science, not politics, when making key decisions about mifepristone.

Researchers are raising new concerns about Chagas disease after finding some very high infection rates in the insects that spread it.